These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 26510945

  • 1. IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in ovarian cancer cells.
    Zou M, Zhang X, Xu C.
    Cell Oncol (Dordr); 2016 Feb; 39(1):47-57. PubMed ID: 26510945
    [Abstract] [Full Text] [Related]

  • 2. Estrogen induced metastatic modulators MMP-2 and MMP-9 are targets of 3,3'-diindolylmethane in thyroid cancer.
    Rajoria S, Suriano R, George A, Shanmugam A, Schantz SP, Geliebter J, Tiwari RK.
    PLoS One; 2011 Jan 18; 6(1):e15879. PubMed ID: 21267453
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3).
    Kandala PK, Srivastava SK.
    BMC Med; 2012 Jan 26; 10():9. PubMed ID: 22280969
    [Abstract] [Full Text] [Related]

  • 5. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
    Ko HS, Park BJ, Choi SK, Kang HK, Kim A, Kim HS, Park IY, Shin JC.
    Yonsei Med J; 2016 May 26; 57(3):761-8. PubMed ID: 26996579
    [Abstract] [Full Text] [Related]

  • 6. 3'3-Diindolylmethane inhibits migration, invasion and metastasis of hepatocellular carcinoma by suppressing FAK signaling.
    Li WX, Chen LP, Sun MY, Li JT, Liu HZ, Zhu W.
    Oncotarget; 2015 Sep 15; 6(27):23776-92. PubMed ID: 26068982
    [Abstract] [Full Text] [Related]

  • 7. Gonadotropin-releasing hormone promotes ovarian cancer cell invasiveness through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase (MMP)-2 and MMP-9.
    Cheung LW, Leung PC, Wong AS.
    Cancer Res; 2006 Nov 15; 66(22):10902-10. PubMed ID: 17108127
    [Abstract] [Full Text] [Related]

  • 8. Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer.
    Jia ZH, Jia Y, Guo FJ, Chen J, Zhang XW, Cui MH.
    PLoS One; 2017 Nov 15; 12(8):e0183622. PubMed ID: 28859117
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Inhibitory effects of matrix metalloproteinase (MMP) inhibitor LY52 on expression of MMP-2 and MMP-9 and invasive ability of human ovarian carcinoma cell line SKOV3].
    Yuan YX, Xu WF, Liu J, Chen MH, Meng H, Qu XJ.
    Ai Zheng; 2006 Jun 15; 25(6):663-70. PubMed ID: 16764758
    [Abstract] [Full Text] [Related]

  • 11. Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.
    Zhao X, Guo X, Shen J, Hua D.
    Mol Med Rep; 2018 Oct 15; 18(4):4030-4036. PubMed ID: 30132572
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells.
    Wang Y, Li L, Guo X, Jin X, Sun W, Zhang X, Xu RC.
    Cytokine; 2012 Aug 15; 59(2):228-36. PubMed ID: 22595649
    [Abstract] [Full Text] [Related]

  • 13. Impact of high glucose on metastasis of colon cancer cells.
    Lin CY, Lee CH, Huang CC, Lee ST, Guo HR, Su SB.
    World J Gastroenterol; 2015 Feb 21; 21(7):2047-57. PubMed ID: 25717237
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma.
    Cao HH, Chu JH, Kwan HY, Su T, Yu H, Cheng CY, Fu XQ, Guo H, Li T, Tse AK, Chou GX, Mo HB, Yu ZL.
    Sci Rep; 2016 Feb 25; 6():21731. PubMed ID: 26911838
    [Abstract] [Full Text] [Related]

  • 15. Lysophosphatidic acid promotes matrix metalloproteinase (MMP) activation and MMP-dependent invasion in ovarian cancer cells.
    Fishman DA, Liu Y, Ellerbroek SM, Stack MS.
    Cancer Res; 2001 Apr 01; 61(7):3194-9. PubMed ID: 11306508
    [Abstract] [Full Text] [Related]

  • 16. Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro.
    Chen L, Liu T, Zhang S, Zhou J, Wang Y, Di W.
    J Ovarian Res; 2014 Dec 10; 7():115. PubMed ID: 25491408
    [Abstract] [Full Text] [Related]

  • 17. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
    Zhang X, Liu P, Zhang B, Mao H, Shen L, Ma Y.
    Int J Mol Med; 2013 Sep 10; 32(3):623-8. PubMed ID: 23828376
    [Abstract] [Full Text] [Related]

  • 18. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
    Tang YJ, Sun ZL, Wu WG, Xing J, He YF, Xin DM, Han P.
    Genet Mol Res; 2015 Mar 30; 14(1):2450-60. PubMed ID: 25867391
    [Abstract] [Full Text] [Related]

  • 19. Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway.
    Ahn JH, Lee KT, Choi YS, Choi JH.
    Prostaglandins Other Lipid Mediat; 2018 Jan 30; 134():47-56. PubMed ID: 29292033
    [Abstract] [Full Text] [Related]

  • 20. [Inhibitory effects of antisense MMP-9 oligodeoxynucleotides on invasiveness and adherence of ovarian cancer cells].
    Hu XX, Li L, Li DR, Zhang W, Tang BJ.
    Zhonghua Zhong Liu Za Zhi; 2006 Sep 30; 28(9):662-5. PubMed ID: 17274370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.